Literature DB >> 3024537

Asbestos exposure and retention as determinants of airway disease and asbestos alveolitis.

R Bégin, S Massé, P Sébastien, J Bossé, M Rola-Pleszczynski, M Boctor, Y Côté, D Fabi, D Dalle.   

Abstract

To evaluate the relationships of asbestos exposure, retention, airway response, and the asbestos alveolitis, we exposed 2 groups of sheep every 2 wk for 3 yr to either 100 ml phosphate-buffered saline (PBS) or 100 mg UICC chrysotile fibers in 100 ml PBS. The sheep were evaluated periodically by pulmonary function tests (PFT), chest radiograph (CR), bronchoalveolar lavage (BAL), and transbronchial lung biopsy (TLB). At Month 24 of the study, all asbestos-exposed sheep had significant increases in lung resistance and upstream resistance. However, only 9 of the 16 asbestos-exposed sheep had significant changes in TLB, CR, Cst, and VC, which clearly separated them from the other 6 sheep in these parameters. The 2 groups, however, had similar air-flow limitation. At lung biopsy, all asbestos-exposed sheep had significant peribronchiolar fibrosis, with significant alveolitis only in the group of 9 sheep with radiographic and functional changes of early asbestosis. The 9 sheep also had significant changes in BAL cellularity and biochemical profile, which differentiated them from the other 6 asbestos-exposed sheep. Analysis of BAL fiber content at that point revealed that despite identical exposure, the group with interstitial lung disease had significantly more fiber retention (p less than 0.01). The data demonstrate that whereas asbestos airway disease appears to be primarily an exposure-dose-related response, the lung response appears to be more closely related to alveolar retention of the dust.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024537     DOI: 10.1164/arrd.1986.134.5.1176

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

1.  Excessive accumulation of asbestos fibre in the bronchoalveolar space may be a marker of individual susceptibility to developing asbestosis: experimental evidence.

Authors:  R Bégin; P Sébastien
Journal:  Br J Ind Med       Date:  1989-12

2.  Effects of phosphorylation of chrysotile on pleuropulmonary fibrogenicity and carcinogenicity.

Authors:  H Daniel; A Wastiaux; P Sébastien; R Bégin
Journal:  Br J Ind Med       Date:  1993-02

3.  Asbestos bodies in bronchoalveolar lavage fluids of brake lining and asbestos cement workers.

Authors:  P Dumortier; P De Vuyst; P Strauss; J C Yernault
Journal:  Br J Ind Med       Date:  1990-02

4.  Mass, number and size of lung fibres in the pathogenesis of asbestosis in sheep.

Authors:  P Sébastien; R Bégin; S Masse
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

5.  Immunogenetic factors as determinants of asbestosis.

Authors:  R Bégin; H Ménard; F Décarie; A St-Sauveur
Journal:  Lung       Date:  1987       Impact factor: 2.584

6.  Patterns of pulmonary dysfunction in asbestos workers: a cross-sectional study.

Authors:  Belayneh A Abejie; Xiaorong Wang; Stefanos N Kales; David C Christiani
Journal:  J Occup Med Toxicol       Date:  2010-06-03       Impact factor: 2.646

7.  Airflow obstruction in nonsmoking, asbestos- and mixed dust-exposed workers.

Authors:  D E Griffith; J G Garcia; R F Dodson; J L Levin; R S Kronenberg
Journal:  Lung       Date:  1993       Impact factor: 2.584

8.  Small interfering RNAs (siRNAs) targeting TGF-beta1 mRNA suppress asbestos-induced expression of TGF-beta1 and CTGF in fibroblasts.

Authors:  Tai-Cheng Lai; Derek A Pociask; MaryBeth Ferris; Hong T Nguyen; Charles A Miller; Arnold Brody; Deborah Sullivan
Journal:  J Environ Pathol Toxicol Oncol       Date:  2009       Impact factor: 3.567

9.  Genetic polymorphism for glutathione-S-transferase mu in asbestos cement workers.

Authors:  K Jakobsson; A Rannug; A K Alexandrie; L Rylander; M Albin; L Hagmar
Journal:  Occup Environ Med       Date:  1994-12       Impact factor: 4.402

10.  Dose-Response Relationships in Expression of Biomarkers of Cell Proliferation in in vitro Assays and Inhalation Experiments.

Authors:  Arti Shukla; Pamela Vacek; Brooke T Mossman
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.